Return on Investment Implications for Pharmaceutical Promotional Expenditures: The Role of Marketing-Mix Interactions
- 1 October 2004
- journal article
- research article
- Published by SAGE Publications in Journal of Marketing
- Vol. 68 (4) , 90-105
- https://doi.org/10.1509/jmkg.68.4.90.42734
Abstract
The authors empirically explore the revenue impact of marketing-mix variables and their interactions. The findings include the following: pharmaceutical direct-to-consumer advertising and detailing (sales force) affect demand synergistically, detailing raises price elasticity, and detailing has a higher return on investment than does direct-to-consumer advertising. The authors also discuss other implications and provide future research directions.Keywords
This publication has 24 references indexed in Scilit:
- Just What the Patient Ordered? Direct-to-Consumer Advertising and the Demand for Pharmaceutical ProductsSSRN Electronic Journal, 2002
- A Practitioner's Guide to Estimation of Random-Coefficients Logit Models of DemandJournal of Economics & Management Strategy, 2000
- A Practitioner's Guide to Estimation of Random‐Coefficients Logit Models of DemandJournal of Economics & Management Strategy, 2000
- Mixed MNL models for discrete responseJournal of Applied Econometrics, 2000
- Advertising and Competition in the Ethical Pharmaceutical Industry: The Case of Antihypertensive DrugsThe Journal of Law and Economics, 1999
- Estimating Discrete-Choice Models of Product DifferentiationThe RAND Journal of Economics, 1994
- A Simple, Positive Semi-Definite, Heteroskedasticity and Autocorrelation Consistent Covariance MatrixEconometrica, 1987
- Rates of Amortization of Advertising ExpendituresJournal of Political Economy, 1971
- Optimal Allocation of Competitive Marketing Efforts: An Empirical StudyThe Journal of Business, 1970
- Optimal Advertising Policy under Dynamic ConditionsEconomica, 1962